Practical Issues for PBMs in Medicare Part D

1 / 7
About This Presentation
Title:

Practical Issues for PBMs in Medicare Part D

Description:

Practical Issues for PBMs in Medicare Part D. Bob Atlas. NASI ... Medco Health Solutions. 80. Publicly traded. Caremark Rx. Lives (Mil.) Ownership. PBM ... – PowerPoint PPT presentation

Number of Views:109
Avg rating:3.0/5.0
Slides: 8
Provided by: boba9
Learn more at: http://www.nasi.org

less

Transcript and Presenter's Notes

Title: Practical Issues for PBMs in Medicare Part D


1
Practical Issues for PBMs in Medicare Part D
  • Bob Atlas
  • NASI Medicare Modernization Conference
  • January 27, 2005

2
Largest PBMs (Total PBMs 70)
Undergoing merger. Figures cannot be summed
possible double counting.
3
4 PBM Medicare Contracting Options
CMS
A
PBMs Own Stand-alone PD Plan
Medicare Advantage PD Plan
Insurers Stand-alone PD Plan
D off limitsif bid forA or B
PBM at risk
B
C
D
Pharmacy Subcontractor
Fallback Plan Contractor
Pharmacy Subcontractor
PBM not at risk for underwriting losses
4
PDP Risks and Risk Buffers
  • SOURCES OF RISK
  • No reliable history
  • Fluidity of drug market
  • Fast-changing product mix
  • Manufacturer price setting
  • Little control over prescribers
  • Skewed enrollment
  • Low take-up
  • Adverse selection
  • RISK PROTECTIONS
  • Plan design rules
  • Formulary guidelines
  • Actuarial equivalence
  • Risk-adjusted rating
  • Government risk sharing
  • Specific case stop-loss
  • Aggregate gain/loss sharing
  • Late enrollment penalty

5
Population-Related Considerations
  • Voluntary enrollment
  • Consumer inertia, confusion, fear
  • Marketing concerns
  • 7 million dual eligibles
  • Drop from Medicaid Rx 1/1/06
  • Auto-enrolled in Medicare PDPFall 05
  • 1.5 million nursing home residents
  • Pharmacy network disconnect
  • Packaging and distribution

Lessons from Rxdiscount card?
6
Drug Selection Formulary Guidelines
  • Government contractor set model guidelines 146
    classes
  • Payers wanted 90 classes Pharma wanted gt200
    classes

2 drugs required in each class
Source U.S. Pharmacopeial Convention, Inc.,
August 2004 and December 2004
7
CONTACT INFORMATIONbob.atlas_at_comcast.net
Write a Comment
User Comments (0)